Vimarsana
Biggest News Aggregation in the World

Page 3 - Target Rwe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Target Rwe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Target Rwe Today - Breaking & Trending Today

Nonalcoholic Fatty Liver Disease (NAFLD) Research from Target RWE's Real-World Study Presented at International Liver Congress 2022 - Vimarsana News

Nonalcoholic Fatty Liver Disease (NAFLD) Research from Target RWE's Real-World Study Presented at International Liver Congress 2022

/PRNewswire/ -- New TARGET-NASH data shows longitudinal trajectories of alanine aminotransferase (ALT) remained comparatively stable among patients with...

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy - Vimarsana News

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy

/PRNewswire/ -- New data shows that more than a third (36.6%) of ulcerative colitis (UC) patients who have previously responded to advanced therapies...

Large Real-World Study Uncovers Higher Prevalence of Non-Alcoholic Fatty Liver Disease Markers, Liver Biopsy, and Cirrhosis in Children - Vimarsana News

Large Real-World Study Uncovers Higher Prevalence of Non-Alcoholic Fatty Liver Disease Markers, Liver Biopsy, and Cirrhosis in Children

/PRNewswire/ -- New real-world data evaluating alanine aminotransferase (ALT) in children uncovered disparities in prevalence and severity of non-alcoholic...

TARGET-IBD Study Reveals Nearly a Third of Patients with Inflammatory Bowel Disease Did Not Undergo Objective Assessment Prior to Biologic Dose Change, Discontinuation - Vimarsana News

TARGET-IBD Study Reveals Nearly a Third of Patients with Inflammatory Bowel Disease Did Not Undergo Objective Assessment Prior to Biologic Dose Change, Discontinuation

/PRNewswire/ -- A new TARGET-IBD study analysis shows one-third of patients with inflammatory bowel disease (IBD) did not have a record of objective disease...

Target RWE Appoints Derek Evans as President - Vimarsana News

Target RWE Appoints Derek Evans as President

/PRNewswire/ -- Target RWE, a leading real-world evidence (RWE) solutions company for the healthcare industry, today announced that Derek Evans, MBA, has...